Trial: 201909024

A Target Validation Study of Fimepinostat in Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG), Recurrent Medulloblastoma, or Recurrent High-Grade Glioma (HGG)

Phase

Early Phase I

Principal Investigator

Abdelbaki, Mohamed

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov